Placebo-controlled trials in pediatric urology: A cautionary view from an ethical perspective

被引：9
|
作者：
Braga, Luis H. P. [1 ]
Bagli, Darius J. [2 ]
Lorenzo, Armando J. [2 ]
机构：
[1] McMaster Univ, Div Pediat Urol, McMasters Children Hosp, Hamilton, ON L8N 3Z5, Canada
[2] Univ Toronto, Hosp Sick Children, Toronto, ON M5S 1A1, Canada
来源：
JOURNAL OF PEDIATRIC UROLOGY | 2010年 / 6卷 / 05期
关键词：
Ethics; Children; Consent form; Placebo; Randomized clinical trials; Narrative review; URINARY-TRACT-INFECTION; ANTIBIOTIC-PROPHYLAXIS; VESICOURETERAL REFLUX; POSTNATAL MANAGEMENT; DOUBLE-BLIND; CHILDREN; INFANTS; HYDRONEPHROSIS; PREVENTION; ENURESIS;
D O I：
10.1016/j.jpurol.2010.02.208
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
The ethical dispute regarding placebo-controlled trials is discussed in this review. Important issues, such as clinical equipoise, fiduciary obligation and middle ground theory, are examined in the context of pediatric urology clinical research. After reviewing the literature, the authors summarize specific indications for placebo-controlled trials in pediatric urology, and emphasize that physicians have ethical and moral obligations to patients, in the sense that one should carefully plan and conduct such trials in order to gain clinically important information without exposing children to undue risks. (C) 2010 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：435 / 442
页数：8
相关论文
共 50 条
  • [1] Placebo-controlled trials in psychiatric research: An ethical perspective
    Miller, FG
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 707 - 716
  • [2] Ethical issues of placebo-controlled trials
    Ferdman, RM
    Church, JA
    JOURNAL OF PEDIATRICS, 1999, 134 (02): : 251 - 251
  • [3] Ethical Considerations for Pediatric Placebo-Controlled Trials: FDA Outcomes and Perspectives
    Momper, Jeremiah D.
    Green, Dionna J.
    Park, Kyunghun
    Burckart, Gilbert J.
    Snyder, Donna L.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (02) : 282 - 303
  • [4] Ethical Considerations for Pediatric Placebo-Controlled Trials: FDA Outcomes and Perspectives
    Jeremiah D. Momper
    Dionna J. Green
    Kyunghun Park
    Gilbert J. Burckart
    Donna L. Snyder
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 282 - 303
  • [5] Placebo-controlled trials in schizophrenia: Are they ethical? Are they necessary?
    Weijer, C
    SCHIZOPHRENIA RESEARCH, 1999, 35 (03) : 211 - 218
  • [6] Psychiatry: Are placebo-controlled drug trials ethical?
    2000, American Assoc for the Advancement of Science, Washington, DC, USA (288)
  • [7] Psychiatry - Are placebo-controlled drug trials ethical?
    Enserink, M
    SCIENCE, 2000, 288 (5465) : 416 - 416
  • [8] The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective
    Laughren, TP
    EUROPEAN PSYCHIATRY, 2001, 16 (07) : 418 - 423
  • [9] Ethical issues in placebo-controlled trials in Alzheimer disease
    Hecker, JR
    Cleland, EG
    Snellgrove, CA
    MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (02) : 104 - 105
  • [10] Ethical considerations in placebo-controlled randomised clinical trials
    Kaufman, Kenneth R.
    BJPSYCH OPEN, 2015, 1 (01): : E3 - E4
12345